The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative

Author:

Díez-Domingo Javier1ORCID,Torcel-Pagnon Laurence2,Carmona Antonio1,Launay Odile3,Dos Santos Gaël4ORCID,Rizzo Caterina5,Haag Mendel6,Stuurman Anke7,Nauta Jos8,Vannacci Alfredo9,de Lusignan Simon10ORCID,Del Rey Elena11,Levi Miriam12ORCID,Lina Bruno13ORCID,Bellino Stefania14ORCID,Nye Samantha15,Neels Pieter16,Nohynek Hanna17,Mahé Cédric2

Affiliation:

1. Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (Fisabio), Valencia, Spain

2. Modeling, Epidemiology and Data Science, Sanofi, Lyon, France

3. Université Paris Descartes, Sorbonne Paris Cité, Inserm CIC 1417, Assistance Publique Hopitaux de Paris (APHP), CIC Cochin-Pasteur, Paris, France

4. GlaxoSmithKline, Wavre, Belgium

5. Functional Area of Clinical Pathways and Epidemiology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

6. Center of Outcomes Research and Epidemiology, Medical Affairs, Seqirus, Amsterdam, The Netherlands

7. P95 Epidemiology & Pharmacovigilance, Heverlee, Belgium

8. Abbott Healthcare Products B.V, CP Weesp, The Netherlands

9. Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Firenze, Italy

10. Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK

11. Synapse Research Management Partners SL (SYNAPSE), Madrid, Spain

12. Azienda USL Toscana Centro, Dipartimento di Prevenzione, Firenze, Italy

13. VirPath Research Laboratory, University Claude Bernard Lyon, Lyon, France

14. Istituto Superiore Di Sanita (ISS), ROMA, Italy

15. Confederation Of Meningitis Organisations Ltd (CoMO), Bristol, UK

16. International Association for Biological Standardization for Europe, Lyon, France

17. Finnish Institute for Health and Welfare, Helsinki, Finland

Funder

Innovative Medicines Initiative

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3